Bio SolutionLtd's earnings have been declining at an average annual rate of -8.6%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 10.6% per year. Bio SolutionLtd's return on equity is 1.6%, and it has net margins of 4.1%.
Key information
-8.62%
Earnings growth rate
-6.57%
EPS growth rate
Biotechs Industry Growth
11.70%
Revenue growth rate
10.65%
Return on equity
1.56%
Net Margin
4.14%
Last Earnings Update
31 Mar 2026
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Bio SolutionLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A086820 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
15,824
655
7,089
6,134
31 Dec 25
15,200
273
6,602
6,306
30 Sep 25
14,369
-10,497
6,419
6,057
30 Jun 25
13,290
-11,139
6,521
5,428
31 Dec 24
12,889
-11,928
6,421
5,755
31 Mar 21
8,275
-1,283
3,446
3,208
31 Dec 20
7,744
-1,800
3,534
3,230
30 Sep 20
7,207
-1,376
2,796
3,719
30 Jun 20
7,331
-1,614
2,902
3,850
31 Dec 19
8,882
-698
3,395
3,645
Quality Earnings: A086820 has a large one-off gain of ₩4.9B impacting its last 12 months of financial results to 31st March, 2026.
Growing Profit Margin: A086820 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A086820 has become profitable over the past 5 years, growing earnings by -8.6% per year.
Accelerating Growth: A086820 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A086820 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (22.6%).
Return on Equity
High ROE: A086820's Return on Equity (1.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/05 03:10
End of Day Share Price
2026/07/03 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bio Solution Co.,Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.